Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,205 shares at $2.53 ($5K) on 2022-11-01, disclosed to the SEC on 2022-12-23.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.53 | 105 | $266 | 5.1% |
| 2 | $2.54 | 105 | $267 | 5.1% |
| 3 | $2.44 | 105 | $256 | 4.9% |
| 4 | $2.42 | 105 | $254 | 4.9% |
| 5 | $2.45 | 105 | $257 | 4.9% |
| 6 | $2.42 | 105 |
| $254 |
| 4.9% |
| 7 | $2.37 | 105 | $249 | 4.8% |
| 8 | $2.37 | 105 | $249 | 4.8% |
| 9 | $2.32 | 105 | $244 | 4.7% |
| 10 | $2.32 | 105 | $244 | 4.7% |
| 11 | $2.35 | 105 | $247 | 4.7% |
| 12 | $2.31 | 105 | $243 | 4.6% |
| 13 | $2.29 | 105 | $240 | 4.6% |
| 14 | $2.27 | 105 | $238 | 4.6% |
| 15 | $2.38 | 105 | $250 | 4.8% |
| 16 | $2.37 | 105 | $249 | 4.8% |
| 17 | $2.29 | 105 | $240 | 4.6% |
| 18 | $2.31 | 105 | $243 | 4.6% |
| 19 | $2.37 | 105 | $249 | 4.8% |
| 20 | $2.34 | 105 | $246 | 4.7% |
| 21 | $2.32 | 105 | $244 | 4.7% |
| Total | $2.37 avg | 2,205 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |